Search
Descriptor English: Brimonidine Tartrate, Timolol Maleate Drug Combination
Descriptor Spanish: Combinación Tartrato de Brimonidina y Maleato de Timolol
Descriptor combinación medicamentosa de tartrato de brimonidina y maleato de timolol
Scope note: Una preparación farmacéutica de tartrato de brimonidina y maleato de timolol. La actividad combinada de estas drogas, como AGONISTAS DE RECEPTORES ADRENÉRGICOS ALFA 2 y como ANTAGONISTAS ADRENÉRGICOS BETA reduce la PRESIÓN INTRAOCULAR en pacientes con GLAUCOMA.
Descriptor Portuguese: Combinação Tartarato de Brimonidina e Maleato de Timolol
Descriptor French: Association de tartrate de brimonidine et de maléate de timolol
Entry term(s): Brimonidine Tartrate Timolol Maleate
Brimonidine Tartrate Timolol Maleate Drug Combination
Brimonidine Tartrate-Timolol Maleate
Brimonidine Tartrate-Timolol Maleate Drug Combination
Combigan
Maleate, Brimonidine Tartrate-Timolol
Tartrate-Timolol Maleate, Brimonidine
Tree number(s): D02.033.100.624.915.500
D02.033.755.624.915.500
D02.092.063.624.915.500
D02.886.675.867.768.500
D03.383.129.708.867.768.500
D03.633.100.857.070.500
D26.310.312
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000068599
Scope note: A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Adrenergic beta-Antagonists
Adrenergic alpha-2 Receptor Agonists
Public MeSH Note: 2016; BRIMONIDINE TARTRATE-TIMOLOL MALEATE DRUG COMBINATION was indexed under QUINOXALINES 2011-2015, under TIMOLOL 2011-2015, and under DRUG COMBINATIONS 2011-2015
History Note: 2016 (2011)
DeCS ID: 55865
Unique ID: D000068599
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2016/05/27
Brimonidine Tartrate, Timolol Maleate Drug Combination - Preferred
Concept UI M000603237
Scope note A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients.
Preferred term Brimonidine Tartrate, Timolol Maleate Drug Combination
Entry term(s) Brimonidine Tartrate Timolol Maleate
Brimonidine Tartrate Timolol Maleate Drug Combination
Brimonidine Tartrate-Timolol Maleate
Brimonidine Tartrate-Timolol Maleate Drug Combination
Maleate, Brimonidine Tartrate-Timolol
Tartrate-Timolol Maleate, Brimonidine
Combigan - Narrower
Concept UI M000603401
Preferred term Combigan



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey